What Should We Know About Prevented, Diagnostic, and Interventional Therapy in Coronary Artery Disease / / edited by Branislav G. Baskot.

The mortality from ischemic heart disease has decreased in recent years. The better understanding of risk factors associated with development of coronary artery disease has significantly contributed to this decline. Improvements in medical and interventional therapy have reduced the complications as...

Full description

Saved in:
Bibliographic Details
TeilnehmendeR:
Place / Publishing House:©2013
Rijeka, Croatia : : IntechOpen,, 2013.
Year of Publication:2013
Language:English
Physical Description:1 online resource (484 pages) :; illustrations
Tags: Add Tag
No Tags, Be the first to tag this record!
id 993546212704498
ctrlnum (CKB)4970000000098609
(NjHacI)994970000000098609
(oapen)https://directory.doabooks.org/handle/20.500.12854/66469
(EXLCZ)994970000000098609
collection bib_alma
record_format marc
spelling Baskot, Branislav G. edt
What Should We Know About Prevented, Diagnostic, and Interventional Therapy in Coronary Artery Disease / edited by Branislav G. Baskot.
IntechOpen 2013
©2013
Rijeka, Croatia : IntechOpen, 2013.
1 online resource (484 pages) : illustrations
text txt rdacontent
computer c rdamedia
online resource cr rdacarrier
Description based on: online resource; title from PDF information screen (InTech, viewed October 18, 2022).
The mortality from ischemic heart disease has decreased in recent years. The better understanding of risk factors associated with development of coronary artery disease has significantly contributed to this decline. Improvements in medical and interventional therapy have reduced the complications associated with acute myocardial infarction as well as revascularization. After the introduction of imaging modalities, the noninvasive characterization of regional function, perfusion and metabolism allowed for more sophisticated tissue characterization to identify reversible dysfunction with high diagnostic and prognostic accuracy. We now can legitimately claim that computed tomography angiography (CTA) of the coronary arteries is available. In the evaluation of patients with suspected coronary artery disease, many guidelines today consider CTA an alternative to stress testing. However the nuclear technique most frequently used by cardiologists is myocardial perfusion imaging (MPI). The combination of a nuclear camera with CTA allows for the attainment of coronary anatomic, cardiac function and MPI from one piece of equipment. Assessing cardiac viability is now fairly routine with these enhancements to cardiac imaging. Traditional coronary angiography presents a variety of limitations related to image acquisition, content, interpretation, and patient safety. Barriers to such improvements include the paucity of clinical outcomes studies related to new imaging technology, the need for physician and staff member training, and the costs associated with acquiring and effectively using these advances in coronary angiography. This issue is full of important information that every cardiologist needs to now.
English
Myocardial reperfusion.
Cardiovascular medicine
953-51-1043-8
Baskot, Branislav G., editor.
language English
format eBook
author2 Baskot, Branislav G.,
author_facet Baskot, Branislav G.,
author2_variant b g b bg bgb
b g b bg bgb
author2_role TeilnehmendeR
title What Should We Know About Prevented, Diagnostic, and Interventional Therapy in Coronary Artery Disease /
spellingShingle What Should We Know About Prevented, Diagnostic, and Interventional Therapy in Coronary Artery Disease /
title_full What Should We Know About Prevented, Diagnostic, and Interventional Therapy in Coronary Artery Disease / edited by Branislav G. Baskot.
title_fullStr What Should We Know About Prevented, Diagnostic, and Interventional Therapy in Coronary Artery Disease / edited by Branislav G. Baskot.
title_full_unstemmed What Should We Know About Prevented, Diagnostic, and Interventional Therapy in Coronary Artery Disease / edited by Branislav G. Baskot.
title_auth What Should We Know About Prevented, Diagnostic, and Interventional Therapy in Coronary Artery Disease /
title_new What Should We Know About Prevented, Diagnostic, and Interventional Therapy in Coronary Artery Disease /
title_sort what should we know about prevented, diagnostic, and interventional therapy in coronary artery disease /
publisher IntechOpen
IntechOpen,
publishDate 2013
physical 1 online resource (484 pages) : illustrations
isbn 953-51-7116-X
953-51-1043-8
callnumber-first R - Medicine
callnumber-subject RC - Internal Medicine
callnumber-label RC685
callnumber-sort RC 3685 I6 W438 42013
illustrated Illustrated
dewey-hundreds 600 - Technology
dewey-tens 610 - Medicine & health
dewey-ones 616 - Diseases
dewey-full 616.124
dewey-sort 3616.124
dewey-raw 616.124
dewey-search 616.124
work_keys_str_mv AT baskotbranislavg whatshouldweknowaboutpreventeddiagnosticandinterventionaltherapyincoronaryarterydisease
status_str n
ids_txt_mv (CKB)4970000000098609
(NjHacI)994970000000098609
(oapen)https://directory.doabooks.org/handle/20.500.12854/66469
(EXLCZ)994970000000098609
carrierType_str_mv cr
is_hierarchy_title What Should We Know About Prevented, Diagnostic, and Interventional Therapy in Coronary Artery Disease /
author2_original_writing_str_mv noLinkedField
_version_ 1758503570023383040
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01048nam a2200289 i 4500</leader><controlfield tag="001">993546212704498</controlfield><controlfield tag="005">20221018080215.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr |||||||||||</controlfield><controlfield tag="008">221018s2013 ci a o 000 0 eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">953-51-7116-X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)4970000000098609</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(NjHacI)994970000000098609</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/66469</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)994970000000098609</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NjHacI</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">NjHacl</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RC685.I6</subfield><subfield code="b">.W438 2013</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">616.124</subfield><subfield code="2">23</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Baskot, Branislav G.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">What Should We Know About Prevented, Diagnostic, and Interventional Therapy in Coronary Artery Disease /</subfield><subfield code="c">edited by Branislav G. Baskot.</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="b">IntechOpen</subfield><subfield code="c">2013</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">©2013</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Rijeka, Croatia :</subfield><subfield code="b">IntechOpen,</subfield><subfield code="c">2013.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (484 pages) :</subfield><subfield code="b">illustrations</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on: online resource; title from PDF information screen (InTech, viewed October 18, 2022).</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The mortality from ischemic heart disease has decreased in recent years. The better understanding of risk factors associated with development of coronary artery disease has significantly contributed to this decline. Improvements in medical and interventional therapy have reduced the complications associated with acute myocardial infarction as well as revascularization. After the introduction of imaging modalities, the noninvasive characterization of regional function, perfusion and metabolism allowed for more sophisticated tissue characterization to identify reversible dysfunction with high diagnostic and prognostic accuracy. We now can legitimately claim that computed tomography angiography (CTA) of the coronary arteries is available. In the evaluation of patients with suspected coronary artery disease, many guidelines today consider CTA an alternative to stress testing. However the nuclear technique most frequently used by cardiologists is myocardial perfusion imaging (MPI). The combination of a nuclear camera with CTA allows for the attainment of coronary anatomic, cardiac function and MPI from one piece of equipment. Assessing cardiac viability is now fairly routine with these enhancements to cardiac imaging. Traditional coronary angiography presents a variety of limitations related to image acquisition, content, interpretation, and patient safety. Barriers to such improvements include the paucity of clinical outcomes studies related to new imaging technology, the need for physician and staff member training, and the costs associated with acquiring and effectively using these advances in coronary angiography. This issue is full of important information that every cardiologist needs to now.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Myocardial reperfusion.</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Cardiovascular medicine</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">953-51-1043-8</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Baskot, Branislav G.,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-02-22 04:01:57 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2019-04-13 22:04:18 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&amp;portfolio_pid=5338126330004498&amp;Force_direct=true</subfield><subfield code="Z">5338126330004498</subfield><subfield code="8">5338126330004498</subfield></datafield></record></collection>